Education
About Us
Working with TipRanks
Follow Us
Daiichi Sankyo Company Limited (DSKYF)
OTHER OTC:DSKYF
Ds3790a, Combination Drug
Hematological Malignancies
Phase I/II
Not Yet Recruiting
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
Oct 21, 2025
―
Rosuvastatin, Bempedoic Acid, Ezetimibe
Healthy Subjects
Phase I
Not Yet Recruiting
Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin
Sep 23, 2025
―
Ds9051b
Metastatic Castration-Resistant Prostate Cancer, Advanced Or Metastatic Adrenocortical Carcinoma
Phase I
Not Yet Recruiting
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
Sep 16, 2025
―
Rosuvastatin, Bempedoic Acid, Ezetimibe
Healthy Subjects
Phase I
Not Yet Recruiting
Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Rosuvastatin
Sep 11, 2025
―
Dato-Dxd
Breast Cancer
Phase III
Not Yet Recruiting
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Sep 11, 2025
―
Ds3610a
Solid Tumors, Metastatic Solid Tumors
Phase I
Not Yet Recruiting
A Study of DS3610a in Participants With Advanced Solid Tumor
Aug 29, 2025
―
Pembrolizumab, Ds5361b
Advanced Solid Tumor
Phase I
Recruiting
A Study of DS5361b in Participants With Advanced Solid Tumors
Aug 27, 2025
―
Nab-paclitaxel, Trastuzumab deruxtecan, Paclitaxel, Capecitabine, Patritumab Deruxtecan, Liposomal Doxorubicin
Breast Neoplasms
Phase III
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Jul 02, 2025
―
Docetaxel, Prednisone, Ifinatamab Deruxtecan
Prostate Cancer, Prostatic Neoplasms
Phase III
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Apr 07, 2025
―
Bempedoic Acid 180 Mg Tablet
Primary Hypercholesterolemia Or Mixed Hyperlipidemia
Phase IV
Recruiting
A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan
Apr 06, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Daiichi Sankyo Company Limited (DSKYF) have in its pipeline
DSKYF is currently developing the following drugs: Ds3790a, Combination Drug, Rosuvastatin, Bempedoic Acid, Ezetimibe, Ds9051b. These drug candidates are in various stages of clinical development as the company works toward FDA approval.